BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32107533)

  • 1. Erdheim-Chester disease.
    Haroche J; Cohen-Aubart F; Amoura Z
    Blood; 2020 Apr; 135(16):1311-1318. PubMed ID: 32107533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
    Haroche J; Papo M; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Presse Med; 2017 Jan; 46(1):96-106. PubMed ID: 27234902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
    Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations.
    Prabhakaran N; Jour G; Balar A; Ward N
    Acta Haematol; 2023; 146(3):245-251. PubMed ID: 36754028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erdheim-Chester disease.
    Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
    Curr Rheumatol Rep; 2014 Apr; 16(4):412. PubMed ID: 24532298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Understanding and Management of Erdheim-Chester Disease.
    Kulkarni AM; Gayam PKR; Aranjani JM
    Life Sci; 2024 Jul; 348():122692. PubMed ID: 38710283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erdheim-Chester disease.
    Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
    Rheum Dis Clin North Am; 2013 May; 39(2):299-311. PubMed ID: 23597965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature.
    Sakr HI; Buckley K; Baiocchi R; Zhao WJ; Hemminger JA
    Diagn Pathol; 2018 Nov; 13(1):94. PubMed ID: 30474563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for BRAF mutation.
    Lu L; Zhou J; Yan X; Jin R; Deng S; Lu W; Chen D
    Medicine (Baltimore); 2023 May; 102(20):e33846. PubMed ID: 37335698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoalphalipoproteinemia and BRAF
    Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.
    Picarsic J; Pysher T; Zhou H; Fluchel M; Pettit T; Whitehead M; Surrey LF; Harding B; Goldstein G; Fellig Y; Weintraub M; Mobley BC; Sharples PM; Sulis ML; Diamond EL; Jaffe R; Shekdar K; Santi M
    Acta Neuropathol Commun; 2019 Nov; 7(1):168. PubMed ID: 31685033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
    Milne P; Bigley V; Bacon CM; Néel A; McGovern N; Bomken S; Haniffa M; Diamond EL; Durham BH; Visser J; Hunt D; Gunawardena H; Macheta M; McClain KL; Allen C; Abdel-Wahab O; Collin M
    Blood; 2017 Jul; 130(2):167-175. PubMed ID: 28512190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erdheim-Chester disease.
    Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
    Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.
    Allen CE; Parsons DW
    Hematology Am Soc Hematol Educ Program; 2015; 2015():559-64. PubMed ID: 26637772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erdheim-Chester Disease: A Case Report of BRAF V600E-Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review.
    Aggarwal A; Taychert M; Hasanin L; Doll D; Basuino MG; Hasanein H
    Oncology (Williston Park); 2023 Jul; 37(7):298-302. PubMed ID: 37499251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
    Haroche J; Abla O
    Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisystem Erdheim-Chester disease presenting with pericardial effusion confirmed by the effusion cytology specimen.
    Dai S; Su X; Liu WP; Wu Y
    Cardiovasc Pathol; 2024; 70():107625. PubMed ID: 38417471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erdheim-Chester Disease: a Concise Review.
    Papo M; Emile JF; Maciel TT; Bay P; Baber A; Hermine O; Amoura Z; Haroche J
    Curr Rheumatol Rep; 2019 Dec; 21(12):66. PubMed ID: 31807955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erdheim-Chester disease with bilateral orbital masses and multi-systemic symptoms: two case reports.
    Qiao J; Ma R; Peng X; He W
    World J Surg Oncol; 2023 Jul; 21(1):233. PubMed ID: 37525276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
    Goyal G; Heaney ML; Collin M; Cohen-Aubart F; Vaglio A; Durham BH; Hershkovitz-Rokah O; Girschikofsky M; Jacobsen ED; Toyama K; Goodman AM; Hendrie P; Cao XX; Estrada-Veras JI; Shpilberg O; Abdo A; Kurokawa M; Dagna L; McClain KL; Mazor RD; Picarsic J; Janku F; Go RS; Haroche J; Diamond EL
    Blood; 2020 May; 135(22):1929-1945. PubMed ID: 32187362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.